Buscar resultados de ensayos clínicos
Noonan Syndrome 1 - 15 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome Condición: Noonan Syndrome Fecha: 2007-03-23 Intervenciones: Drug: MAXOMAT ®, biosynthetic growth hormone 2 posologies according to age (children and adolescent |
Recruiting |
Nombre del estudio: Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome Condición: Noonan Syndrome Fecha: 2016-03-09 Intervenciones:
|
Terminated |
Nombre del estudio: Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome Condición: Noonan Syndrome Fecha: 2006-07-11 Intervenciones: Drug: rhIGF-1/rhIGFBP-3 |
Completed |
Nombre del estudio: Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome Condición:
Fecha: 2012-01-02 Intervenciones: Drug: somatropin Retrospective data collection based on data obtained from a prospective, open-label, ra |
Active, not recruiting |
Nombre del estudio: Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome Condición:
Fecha: 2013-08-20 Intervenciones: Drug: somatropin Administered subcutaneously (s.c., under the skin) in a daily regimen for at least 104 |
Not yet recruiting |
Nombre del estudio: Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes Condición:
Fecha: 2014-03-04 |
Completed |
Nombre del estudio: Study of Metabolic Modifications in Children With Noonan Syndrome Condición: Child Syndrome Fecha: 2014-12-23 Intervenciones: Other: Oral Glucose tolerance test Oral glucose tolerance test (OGTT): glucose and insulin levels will b |
Withdrawn |
Nombre del estudio: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy Condición: Cardiomegaly Fecha: 2012-03-15 Intervenciones: Drug: MEK162 |
Completed |
Nombre del estudio: Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658 Condición:
Fecha: 2012-01-02 Intervenciones: Drug: somatropin Results from a genetic testing for the PTPN11 mutation will be collected retrospectivel |
Completed |
Nombre del estudio: Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol Condición: Mass Screening Fecha: 2010-10-19 Intervenciones: Device: Bio-Rad Platelia Dengue NS1 Ag test The purpose of the study is to screen blood donors for the p |